Dabrafenib CAS NO.1195765-45-7

Short Description:

Product Name:Dabrafenib

CAS NO.:1195765-45-7

Synonyms:

N-[3-[5-(2-Amino-4-pyrimidinyl)-2-(tert-butyl)-4-thiazolyl]-2-fluorophenyl]-2,6-difluorobenzenesulfonamide;

Dabrafenibfreebase(GSK2118436A);

Dabrafenib(GChemicalbookSK2118436);

GSK2118436A;

Dabrafenib(GSK2118436A);

CS-658;

N-[3-[5-(2-aminopyrimidin-4-yl)-2-tert-butyl-1,3-thiazol-4-yl]-2-fluorophenyl]-2,6-difluorobenzenesulfonamide

Related Categories:Medical raw materials; cell biology reagents; active pharmaceutical ingredients (APIs); anti-tumor agents; API intermediates; signal transduction pathway kinase inhibitors; small molecule inhibitors; inhibitors; small molecule inhibitors, natural products; pharmaceutical raw materials Chemicalbook; pharmaceutical raw materials; APIs and intermediates; scientific research export category; raw materials; chemical reagents; RafB protein kinase inhibitor; inhibitor; MAPK; API

Send email to us

Product Detail

Product Tags

Product Information

Name	Dabrafenib
CAS NO.	1195765-45-7
Molecular Formula	C23H20F3N5O2S2	Molecular Weight	519.56
MDL No.	N.A.	EINECS	689-166-9
M.P.	214-216℃	B.P.	653.7±65.0 °C(Predicted)
Density	1.443	Refractive Index	N.A.
F.P.	N.A.	Storage condition	-20°C

Appearance	White powder
Purity
Application	Can inhibit tumor growth
Supply Ability	Dabrafenib CAS NO.1195765-45-7 is our regularly production product, whether you need small sample or a large cargo of more than tonnage, our company can supply it formally

Contact Information

If you are interested in Dabrafenib CAS NO.1195765-45-7 , feel freely contact us please, and we will provide you the best quality products, reasonable price and best service, expecting to our cooperation.

E-Mail

info@leichi-chem.com

charleen@leichi-chem.com

Phone No.

+86 139 6251 3054

+86 136 2174 3828

The products listed by the company involve patents, which are only for research and development and not for sale; controlled products will be sold in strict compliance with Chinese laws and the laws of the country where they are purchased, and all products are not suitable for human use. If sold, they will constitute patent infringement country, all corresponding risks will be borne by the buyer.

Previous: Asundexian (BAY 2433334) CAS NO.2064121-65-7

Next: Vismodegib CAS NO.879085-55-9

1195765-45-7